Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 30;7(11):ofaa461.
doi: 10.1093/ofid/ofaa461. eCollection 2020 Nov.

Epidemiology and Risk Factors Associated With Mortality in Consecutive Patients With Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria

Affiliations

Epidemiology and Risk Factors Associated With Mortality in Consecutive Patients With Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria

Antonella Santoro et al. Open Forum Infect Dis. .

Abstract

Background: Mortality related to bloodstream infections (BSIs) is high. The epidemiology of BSIs is changing due to the increase in multidrug resistance, and it is unclear whether the presence of multidrug-resistant (MDR) organisms, per se, is an independent risk factor for mortality. Our objectives were, first, to describe the epidemiology and outcome of BSIs and, second, to determine the risk factors associated with mortality among patients with BSI.

Methods: This research used a single-center retrospective observational study design. Patients were identified through microbiological reports. Data on medical history, clinical condition, bacteria, antimicrobial therapy, and mortality were collected. The primary outcome was crude mortality at 30 days. The relationships between mortality and demographic, clinical, and microbiological variables were analyzed by multivariate analysis.

Results: A total of 1049 inpatients were included. MDR bacteria were isolated in 27.83% of patients, where 2.14% corresponded to an extremely drug-resistant (XDR) isolate. The crude mortality rates at days 7, 30, and 90 were 12.11%, 25.17%, and 36.13%, respectively. Pitt score >2, lung and abdomen as site of infection, and XDR Pseudomonas aeruginosa were independent risk factors for 7-, 30-, and 90-day mortality. Charlson score >4, carbapenem-resistant Klebsiella pneumoniae, and XDR Acinetobacter baumannii were independent risk factors for 30- and 90-day mortality. Infection by XDR gram-negative bacteria, Charlson score >4, and immunosuppression were independent risk factors for mortality in patients who were stable at the time of BSI.

Conclusions: BSI is an event with an extreme impact on mortality. Patients with severe clinical condition are at higher risk of death. The presence of XDR gram-negative bacteria in blood is strongly and independently associated with patient death.

Keywords: MDR; P. aeruginosa; XDR; bloodstream infection; gram-negative bacteria; hospital.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Bacterial epidemiology of bloodstream infections (n = 1598 isolates). Abbreviations: BSI, bloodstream infection, CoNS, coagulase-negative staphylococci.
Figure 2.
Figure 2.
A, Patient survival curves according to antibiotic resistance category of isolates (all patients n = 1049). B, Survival curves of patients with gram-negative (n = 580) or gram-positive (n = 469) BSI isolates, according to antibiotic resistance category. Abbreviations: BSI, bloodstream infection; Central cath, central venous catheter; MDR, multidrug-resistant; No MDR, R <3 categories; PDR, pandrug-resistant; Res >6 categories, XDR and PDR categories for gram-negative bacteria; XDR, extensively drug-resistant.
Figure 3.
Figure 3.
Multivariate analysis for mortality in patients with gram-negative BSI (n = 580). Abbreviations: BSI, bloodstream infection; HR, hazard ratio; PDR, pandrug-resistant; Res >6 categories, XDR and PDR categories for gram-negative bacteria; XDR, extensively drug-resistant.

References

    1. Søgaard M, Nørgaard M, Dethlefsen C, Schønheyder HC. Temporal changes in the incidence and 30-day mortality associated with bacteremia in hospitalized patients from 1992 through 2006: a population-based cohort study. Clin Infect Dis 2011; 52:61–9. - PubMed
    1. Wilson J, Elgohari S, Livermore DM, et al. Trends among pathogens reported as causing bacteraemia in England, 2004-2008. Clin Microbiol Infect 2011; 17:451–8. - PubMed
    1. Deen J, von Seidlein L, Andersen F, et al. Community-acquired bacterial bloodstream infections in developing countries in South and Southeast Asia: a systematic review. Lancet Infect Dis 2012; 12:480–7. - PubMed
    1. Bartoletti M, Giannella M, Caraceni P, et al. Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. J Hepatol 2014; 61:51–8. - PubMed
    1. Trecarichi EM, Pagano L, Candoni A, et al. ; HeMABIS Registry—SEIFEM Group, Italy Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey. Clin Microbiol Infect 2015; 21:337–43. - PubMed